The usage of antidiabetic drugs : a managed care approach / Rianda Steyn

The usage of antidiabetic drugs : a managed care approach / Rianda Steyn

Show other versions (1)

"Diabetes mellitus" refers to a spectrum of conditions, which all present with hyperglycaemia as a common medical finding. Diabetes was once thought of as a single disease, but according to Setter et a/. (2000:378), it includes a heterogeneous group of disorders that are secondary to vario...

Full description

Bibliographic Details
Main Author:	Steyn, Rianda
Published:	North-West University 2009
Subjects:	Diabetes mellitus Type one Type two Managed care Pharmaco-economics Drug utilisation review Oral antidiabetic agents Insulins Single exit price Cost savings Generic Innovator
Online Access:	http://hdl.handle.net/10394/1029

Similar Items

The usage of antidiabetic drugs : a managed care approach / Rianda Steyn
by: Steyn, Rianda
Published: (2009)

Antidiabetic agents and cancer outcomes: Are there differences between agents?
by: Bowker, Samantha Lyndsey
Published: (2009)

Effects of short-term combination therapy with insulin on glycoregulation and insulin secretory function in patients with type 2 diabetes mellitus and secondary failure to treatment with oral antidiabetic agents
by: Gabrijela Malešević, et al.
Published: (2019-07-01)

Consensus statement on dose modifications of antidiabetic agents in patients with hepatic impairment
by: Kalyan Kumar Gangopadhyay, et al.
Published: (2017-01-01)

Dose modification of antidiabetic agents in patients with type 2 diabetes mellitus and heart failure
by: D C Sharma, et al.
Published: (2017-01-01)

Evaluation of Oral Antidiabetic Dosing and Drug Interactions in Type 2 Diabetic Patients
by: Nova Hasani Furdiyanti, et al.
Published: (2018-02-01)

Clinical Experience with Biphasic Insulin Aspart 30 Treatment in Patients with Type 2 Diabetes Poorly Controlled on Oral Antidiabetic Drugs: The Turkish PRESENT Study
by: Serdar Güler, et al.
Published: (2008-05-01)

How many oral antidiabetic drugs before insulin?
by: Jayant Kelwade, et al.
Published: (2017-01-01)

Conventional antidiabetic agents and bone health: A pilot case–control study
by: Jeffrey Pradeep Raj, et al.
Published: (2019-01-01)

Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea
by: Sung Hee Choi, et al.
Published: (2017-05-01)

The Selection of Oral Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients with High Risk for Cardiovascular Events
by: Derlin J. Leander, et al.
Published: (2020-12-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
by: Varsha Bangalee, et al.
Published: (2016-10-01)

Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
by: Varsha Bangalee, et al.
Published: (2016-12-01)

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
by: Pscherer S, et al.
Published: (2016-02-01)

Renal Outcomes Associated with the Use of Non-Insulin Antidiabetic Pharmacotherapy: A Review of Current Evidence and Recommendations
by: Elnaem MH, et al.
Published: (2020-12-01)

Sodium-glucose co-transporter 2 (SGLT2) inhibitors: a growing class of anti-diabetic agents
by: Eva M Vivian
Published: (2014-12-01)

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53)
by: Hiroshi Maegawa, et al.
Published: (2021-03-01)

Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial
by: Wen‐Huan Feng, et al.
Published: (2019-03-01)

Molecular docking and prediction of ADME/drug-likeness properties of potentially active antidiabetic compounds isolated from aqueous-methanol extracts of Gymnema sylvestre and Combretum micranthum
by: Chimaobi Ononamadu, et al.
Published: (2021-03-01)

Practical combination therapy based on pathophysiology of type 2 diabetes
by: Levin PA
Published: (2016-10-01)

Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
by: Chengxia Kan, et al.
Published: (2021-09-01)

A new class of potential antidiabetic acetohydrazides: Synthesis, in vivo antidiabetic activity and molecular docking studies
by: Mubeen Arif, et al.
Published: (2017-09-01)

Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes
by: Adeyemi, Ayoade Olayemi
Published: (2011)

Antidiabetic effect of fucoxanthin extracted from Sargassum angustifolium on streptozotocin‐nicotinamide‐induced type 2 diabetic mice
by: Najme Oliyaei, et al.
Published: (2021-07-01)

Comparing treatment intensification and clinical outcomes of metformin and dipeptidyl peptidase‐4 inhibitors in treatment‐naïve patients with type 2 diabetes in Japan
by: Takeshi Horii, et al.
Published: (2020-01-01)

Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis
by: Yue Fei, et al.
Published: (2019-08-01)

Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
by: E. Lin, et al.
Published: (2020-06-01)

Pharmacogenetics of new classes of antidiabetic drugs
by: Selma Imamovic Kadric, et al.
Published: (2021-04-01)

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
by: Bao Sun, et al.
Published: (2021-01-01)

Antidiabetic Components Contained in Vegetables and Legumes
by: Hong-Yu Zhang, et al.
Published: (2008-05-01)

A stewardship intervention program for safe medication management and use of antidiabetic drugs
by: Zhao RY, et al.
Published: (2015-07-01)

Physicochemical, Nutritional and In Vitro Antidiabetic Characterisation of Blue Whiting (<i>Micromesistius</i><i>poutassou</i>) Protein Hydrolysates
by: Pádraigín A Harnedy-Rothwell, et al.
Published: (2021-07-01)

Population-Based Registry Analysis of Antidiabetics Dispensations: Trend Use in Spain between 2015 and 2018 with Reference to Driving
by: Eduardo Gutiérrez-Abejón, et al.
Published: (2020-07-01)

Effects of Antidiabetic Drugs on Gut Microbiota Composition
by: Sophie A. Montandon, et al.
Published: (2017-09-01)

Systematic Review of Efficacy and Safety of Newer Antidiabetic Drugs Approved from 2013 to 2017 in Controlling HbA1c in Diabetes Patients
by: Sivanandy Palanisamy, et al.
Published: (2018-06-01)

Effects of Momordica Charantia Seed Extract on Dexamethasone-Induced Biochemical and Histological Abnormalities in Albino Rats
by: DASARAJU RAJESH, et al.
Published: (2020-10-01)

Marketing analysis of some groups antidiabetic medicines, presented at pharmaceutical market of Ukraine
by: I. V. Vyshnytska, et al.
Published: (2018-08-01)

South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan
by: Md Faruque Pathan, et al.
Published: (2012-01-01)

Real World Use of Antidiabetic Drugs in the Years 2011–2017: A Population-Based Study from Southern Italy
by: Ylenia Ingrasciotta, et al.
Published: (2020-12-01)

COST ANALYSIS OF ANTIDIABETIC DRUGS FOR DIABETES MELLITUS OUTPATIENT IN KODYA YOGYAKARTA HOSPITAL
by: TRI MURTI ANDAYANI, et al.
Published: (2007-01-01)